FCGR1A and cancer: Increased levels of CD64 (Fcγ-receptor 1) have been associated with monocyte activation and found to be elevated in cancer patients relative to normal donors.31,32 Our data demonstrate that treatment with low-dose radiation reduced CD64 expression on monocytes in circulation.